Nanopublication

< Home

ID

http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0

Formats

.trig | .trig.txt | .jelly | .jelly.txt

Content

@prefix dc1: <http://purl.org/dc/terms/> .
@prefix this: <http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0> .
@prefix sub: <http://purl.org/np/RA_Vkv-dxa5Rox9wp8aXHvZeBwvV0Jrh_xVosifNFcJb0#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo .
}

sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_3078> bl:category bl:Disease .
  
  sub:association a rdf:Statement;
    rdf:object <http://purl.obolibrary.org/obo/DOID_3078>;
    rdf:predicate bl:treats;
    rdf:subject <https://identifiers.org/drugbank:DB00853>;
    rdfs:label "temozolomide capsules are an alkylating drug indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme gbm concomitantly with radiotherapy and then as maintenance treatment 1 1 refractory anaplastic astrocytoma patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine 1 2 temozolomide capsules are indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment temozolomide capsules are indicated for the treatment of adult patients with refractory anaplastic astrocytoma i e patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine";
    bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
    bl:provided_by <https://w3id.org/um/NeuroDKG>;
    bl:relation schema:TreatmentIndication .
  
  <https://identifiers.org/drugbank:DB00853> bl:category bl:Drug .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
    npx:hasSignature "fNfZrtG+k2qx5pKlQKatBfi44u1ikkOMfBSszrwbFXO4c8oDneCPxq09WFD8fL/AiamWX4NXHl2jmJ5KWpWJk0gsbCEqxCcuw6zT6Sz6AtAi8tn7hBIAllso8gIX7QoHnGqdzDsEjLPqJGIrmsVxThMmNYlOEoWqAVmB5vnjNA4=";
    npx:hasSignatureTarget this: .
  
  this: dc1:created "2021-06-12T16:49:29.885+02:00"^^xsd:dateTime;
    dc1:creator orcid:0000-0002-1468-3557;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
    nt:wasCreatedFromTemplate <http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs> .
}